{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:46:30Z","timestamp":1791999990795,"version":"4.4.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jbc.2026.111335","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:59:05Z","timestamp":1772294345000},"page":"111335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Apolipoprotein M: Structural insights, functional roles, and therapeutic approaches in vascular disease"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2741-7298","authenticated-orcid":false,"given":"Tim F.","family":"Dorweiler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8355-4065","authenticated-orcid":false,"given":"Timothy","family":"Hla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.111335_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jbc.2026.111335_bib2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jbc.2026.111335_bib3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1210\/clinem\/dgae388","article-title":"Plasma ceramides predict all-cause and cause-specific mortality in individuals with type 2 diabetes","volume":"110","author":"Liu","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2026.111335_bib4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.tips.2021.10.001","article-title":"Cholesterol - the devil you know; ceramide - the devil you don't","volume":"42","author":"Tippetts","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2026.111335_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111335_bib6","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.3390\/ijms241814015","article-title":"Circulating sphingolipids in insulin resistance, diabetes and associated complications","volume":"24","author":"Hammad","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2026.111335_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13321-017-0205-3","article-title":"Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library","volume":"9","author":"Tsugawa","year":"2017","journal-title":"J. Cheminform"},{"key":"10.1016\/j.jbc.2026.111335_bib9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41580-024-00742-y","article-title":"Regulation of cellular and systemic sphingolipid homeostasis","volume":"25","author":"Kuo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2026.111335_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nature14462","article-title":"HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation","volume":"523","author":"Blaho","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111335_bib11","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111335_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2026.111335_bib13","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","article-title":"A novel human apolipoprotein (apoM)","volume":"274","author":"Xu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/clinem\/dgaf378","article-title":"Plasma sphingolipids in relation to glycemia and glucose tolerance in people without diabetes","volume":"111","author":"Asuzu","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2026.111335_bib15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/dc23-2441","article-title":"Circulating metabolite biomarkers of glycemic control in youth-onset type 2 Diabetes","volume":"47","author":"Chen","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbc.2026.111335_bib16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12192-020-01153-6","article-title":"Lipid chaperones and associated diseases: a group of chaperonopathies defining a new nosological entity with implications for medical research and practice","volume":"25","author":"D'Anneo","year":"2020","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jbc.2026.111335_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","article-title":"High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target","volume":"114","author":"Luscher","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1078\/0065-1281-00687","article-title":"Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization","volume":"105","author":"Zhang","year":"2003","journal-title":"Acta Histochem."},{"key":"10.1016\/j.jbc.2026.111335_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6729","article-title":"Enterically derived high-density lipoprotein restrains liver injury through the portal vein","volume":"373","author":"Han","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111335_bib19","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/ajcn\/nqy331","article-title":"Apolipoprotein M: a novel adipokine decreasing with obesity and upregulated by calorie restriction","volume":"109","author":"Sramkova","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jbc.2026.111335_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-3-21","article-title":"Apolipoprotein M","volume":"3","author":"Luo","year":"2004","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jbc.2026.111335_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOL.0000000000000142","article-title":"Apolipoprotein M in lipid metabolism and cardiometabolic diseases","volume":"26","author":"Borup","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jbc.2026.111335_bib22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00018-009-8764-8","article-title":"Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?","volume":"66","author":"Dahlback","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jbc.2026.111335_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/db19-0811","article-title":"Protection against insulin resistance by Apolipoprotein M\/Sphingosine-1-Phosphate","volume":"69","author":"Kurano","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2026.111335_bib24","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s11033-012-2240-5","article-title":"Association of the apolipoprotein M gene polymorphisms and serum lipid levels","volume":"40","author":"Aung","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jbc.2026.111335_bib25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.RES.0000122383.60368.24","article-title":"Point-counterpoint of sphingosine 1-phosphate metabolism","volume":"94","author":"Saba","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/mmr.2015.3658","article-title":"Apolipoprotein M: research progress, regulation and metabolic functions (Review)","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2026.111335_bib156","doi-asserted-by":"crossref","first-page":"105031","DOI":"10.1016\/j.isci.2022.105031","article-title":"The known unknowns of apolipoprotein glycosylation in health and disease","volume":"25","author":"Subramanian","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jbc.2026.111335_bib28","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.cub.2025.03.082","article-title":"Intercellular sphingolipid signaling mediates aversive learning in C. elegans","volume":"35","author":"Wu","year":"2025","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2026.111335_bib29","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1194\/jlr.RA119000277","article-title":"Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice","volume":"60","author":"Obinata","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jbc.2026.111335_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","article-title":"Vascular endothelium as a contributor of plasma sphingosine 1-phosphate","volume":"102","author":"Venkataraman","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib31","doi-asserted-by":"crossref","first-page":"37118","DOI":"10.1074\/jbc.M502207200","article-title":"SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism","volume":"280","author":"Maceyka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038941","article-title":"Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells","volume":"7","author":"Hisano","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111335_bib33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1167449","article-title":"The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors","volume":"323","author":"Kawahara","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111335_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature24053","article-title":"Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets","volume":"550","author":"Vu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111335_bib35","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.279.5356.1552","article-title":"Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1","volume":"279","author":"Lee","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jbc.2026.111335_bib36","first-page":"985","article-title":"Targeting Sphingosine-1-Phosphate signaling in immune-mediated diseases","volume":"81","author":"Perez-Jeldres","year":"2021","journal-title":"Beyond Mult. Scler. Drugs"},{"key":"10.1016\/j.jbc.2026.111335_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/geno.1998.5491","article-title":"EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue","volume":"53","author":"Graler","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.jbc.2026.111335_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6059203","article-title":"Beyond immune cell migration: the emerging role of the Sphingosine-1-phosphate receptor S1PR4 as a modulator of innate immune cell activation","volume":"2017","author":"Olesch","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.jbc.2026.111335_bib39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3748\/wjg.v16.i15.1859","article-title":"Effect of S1P5 on proliferation and migration of human esophageal cancer cells","volume":"16","author":"Hu","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jbc.2026.111335_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cellsig.2013.11.024","article-title":"Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells","volume":"26","author":"Huang","year":"2014","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2026.111335_bib41","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1172\/JCI28295","article-title":"Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function","volume":"116","author":"Idzko","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib42","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0306-4522(02)00791-1","article-title":"Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS","volume":"116","author":"Terai","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.jbc.2026.111335_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1742-2094-9-133","article-title":"Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier","volume":"9","author":"van Doorn","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jbc.2026.111335_bib44","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/ni1523","article-title":"Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor","volume":"8","author":"Walzer","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2026.111335_bib46","article-title":"Binding characteristics of Sphingosine-1-Phosphate to ApoM hints to assisted release mechanism via the ApoM calyx-opening","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2026.111335_bib47","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1194\/jlr.D068866","article-title":"A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the kinetic exclusion assay","volume":"57","author":"Fleming","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jbc.2026.111335_bib48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1042\/BCJ20190730","article-title":"Mechanism of sphingosine 1-phosphate clearance from blood","volume":"477","author":"Kharel","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2026.111335_bib49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcb.21665","article-title":"S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake","volume":"104","author":"Peest","year":"2008","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.jbc.2026.111335_bib50","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1194\/jlr.M039685","article-title":"Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice","volume":"54","author":"Salous","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jbc.2026.111335_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal2722","article-title":"An engineered S1P chaperone attenuates hypertension and ischemic injury","volume":"10","author":"Swendeman","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2026.111335_bib52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41467-022-28417-2","article-title":"Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111335_bib53","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41422-021-00566-x","article-title":"Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition","volume":"31","author":"Yuan","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2026.111335_bib54","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","article-title":"Sphingosine-1-phosphate and its receptors: structure, signaling, and influence","volume":"82","author":"Rosen","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2026.111335_bib55","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s12272-010-1008-5","article-title":"Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib56","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181612","article-title":"S1P(1) receptor phosphorylation, internalization, and interaction with rab proteins: effects of sphingosine 1-phosphate, FTY720-P, phorbol esters, and paroxetine","volume":"38","author":"Martinez-Morales","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jbc.2026.111335_bib57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/tra.12343","article-title":"Endocytosis of ligand-activated sphingosine 1-Phosphate receptor 1 mediated by the clathrin-pathway","volume":"17","author":"Reeves","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.jbc.2026.111335_bib58","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI45403","article-title":"Engagement of S1P(1)-degradative mechanisms leads to vascular leak in mice","volume":"121","author":"Oo","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib59","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","article-title":"Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor","volume":"282","author":"Oo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib60","doi-asserted-by":"crossref","first-page":"44645","DOI":"10.1074\/jbc.M112.423426","article-title":"Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1","volume":"287","author":"Wilkerson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib61","doi-asserted-by":"crossref","first-page":"19672","DOI":"10.1074\/jbc.M009993200","article-title":"Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein\/phosphoinositide 3-kinase pathway in endothelial cells","volume":"276","author":"Morales-Ruiz","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"Suppl B","key":"10.1016\/j.jbc.2026.111335_bib62","first-page":"7B","article-title":"The pivotal role of nitric oxide for vascular health","volume":"20","author":"Cooke","year":"2004","journal-title":"Can J. Cardiol."},{"key":"10.1016\/j.jbc.2026.111335_bib63","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(02)00327-9","article-title":"Vasoprotection by nitric oxide: mechanisms and therapeutic potential","volume":"55","author":"Gewaltig","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib64","first-page":"147","article-title":"Vascular nitric oxide: formation and function J","volume":"2010","author":"Jin","year":"2010","journal-title":"Blood Med."},{"key":"10.1016\/j.jbc.2026.111335_bib65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","article-title":"Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2026.111335_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171467","article-title":"Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis","volume":"9","author":"Burg","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.111335_bib67","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1618659114","article-title":"Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1","volume":"114","author":"Yanagida","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.111335_bib68","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49405","article-title":"Apolipoprotein M-bound sphingosine-1-phosphate regulates blood-brain barrier paracellular permeability and transcytosis","volume":"8","author":"Mathiesen Janiurek","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2026.111335_bib69","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/ATVBAHA.121.316725","article-title":"Apolipoprotein M and Sphingosine-1-Phosphate receptor 1 promote the transendothelial transport of high-density lipoprotein","volume":"41","author":"Velagapudi","year":"2021","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2026.111335_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: from simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2026.111335_bib71","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/ATVBAHA.107.143735","article-title":"Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN","volume":"27","author":"Sanchez","year":"2007","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2026.111335_bib72","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1172\/JCI31123","article-title":"Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina","volume":"117","author":"Skoura","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib73","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.1038\/ncomms8893","article-title":"Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke","volume":"6","author":"Kim","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111335_bib74","doi-asserted-by":"crossref","first-page":"30719","DOI":"10.1074\/jbc.M110.131771","article-title":"Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors","volume":"285","author":"Mosialou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib75","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/dme.12066","article-title":"Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes","volume":"30","author":"Mughal","year":"2013","journal-title":"Diabet Med."},{"key":"10.1016\/j.jbc.2026.111335_bib76","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1074\/jbc.M706382200","article-title":"Regulation of anti-atherogenic apolipoprotein M gene expression by the orphan nuclear receptor LRH-1","volume":"283","author":"Venteclef","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib77","doi-asserted-by":"crossref","first-page":"14011","DOI":"10.1074\/jbc.M105403200","article-title":"Analysis of gene expression profile induced by hepatocyte nuclear factor 4alpha in hepatoma cells using an oligonucleotide microarray","volume":"277","author":"Naiki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12944-017-0458-x","article-title":"17beta-estradiol regulates the expression of apolipoprotein M through estrogen receptor alpha-specific binding motif in its promoter","volume":"16","author":"Wei","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jbc.2026.111335_bib79","doi-asserted-by":"crossref","first-page":"17259","DOI":"10.1074\/jbc.M110.200659","article-title":"Opposite regulation of the human apolipoprotein M gene by hepatocyte nuclear factor 1 and Jun transcription factors","volume":"286","author":"Mosialou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2007.10.007","article-title":"Infection and inflammation decrease apolipoprotein M expression","volume":"199","author":"Feingold","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jbc.2026.111335_bib81","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2337\/db18-0674","article-title":"Novel mechanism of Foxo1 phosphorylation in Glucagon signaling in control of glucose homeostasis","volume":"67","author":"Wu","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jbc.2026.111335_bib82","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111335_bib83","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146219","article-title":"Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M\/sphingosine-1-phosphate pathway","volume":"132","author":"Izquierdo","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bbalip.2006.02.002","article-title":"Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells","volume":"1761","author":"Xu","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2026.111335_bib85","first-page":"3785","article-title":"Atorvastatin upregulates apolipoprotein M expression via attenuating LXRalpha expression in hyperlipidemic apoE-deficient mice","volume":"16","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib86","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-016-0325-1","article-title":"Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study","volume":"15","author":"Zhang","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jbc.2026.111335_bib87","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41366-024-01510-w","article-title":"Identification of circulating apolipoprotein M as a new determinant of insulin sensitivity and relationship with adiponectin","volume":"48","author":"Frances","year":"2024","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.jbc.2026.111335_bib88","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jdi.12232","article-title":"Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice","volume":"5","author":"Nojiri","year":"2014","journal-title":"J. Diabetes Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib89","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/ATVBAHA.124.322367","article-title":"ApoM and major adverse cardiovascular events in chronic kidney disease: a prospective cohort Study","volume":"45","author":"Stadler","year":"2025","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.jbc.2026.111335_bib90","first-page":"99","article-title":"The link between chronic kidney disease and cardiovascular disease","volume":"3","author":"Said","year":"2014","journal-title":"J. Nephropathol."},{"key":"10.1016\/j.jbc.2026.111335_bib91","article-title":"The apoM\/S1P Complex-A mediator in kidney biology and disease?","volume":"8","author":"Bisgaard","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jbc.2026.111335_bib92","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.201500064","article-title":"Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1","volume":"30","author":"Christensen","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111335_bib93","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1096\/fj.201801748R","article-title":"Apolipoprotein M suppresses the phenotypes of IgA nephropathy in hyper-IgA mice","volume":"33","author":"Kurano","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2026.111335_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.trsl.2023.02.004","article-title":"Apolipoprotein M\/sphingosine 1-phosphate protects against diabetic nephropathy","volume":"258","author":"Kurano","year":"2023","journal-title":"Transl Res."},{"key":"10.1016\/j.jbc.2026.111335_bib95","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2009060662","article-title":"Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury","volume":"21","author":"Bajwa","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jbc.2026.111335_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000298339","article-title":"Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation","volume":"31","author":"Kim","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.jbc.2026.111335_bib97","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2026.111335_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101800","article-title":"Dapagliflozin's Association with cardiorenal outcomes and Apolipoprotein M levels in HFrEF patients: insights from DEFINE-HF","volume":"4","author":"Sauer","year":"2025","journal-title":"JACC Adv."},{"key":"10.1016\/j.jbc.2026.111335_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101839","article-title":"Sodium-Glucose cotransporter inhibition preserves Apolipoprotein M during acute inflammation in mice and humans","volume":"4","author":"Valenzuela Ripoll","year":"2025","journal-title":"JACC Adv."},{"key":"10.1016\/j.jbc.2026.111335_bib100","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.jbc.2026.111335_bib101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12944-016-0228-1","article-title":"High apolipoprotein M serum levels correlate with chronic obstructive pulmonary disease","volume":"15","author":"Li","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jbc.2026.111335_bib102","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacbts.2022.09.010","article-title":"Apolipoprotein M attenuates Anthracycline cardiotoxicity and lysosomal injury","volume":"8","author":"Guo","year":"2023","journal-title":"JACC Basic Transl Sci."},{"key":"10.1016\/j.jbc.2026.111335_bib103","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1038\/s41467-025-60750-0","article-title":"HDL-bound S1P affects the subventricular niche and early neuropathological features of Alzheimer's disease","volume":"16","author":"Choi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111335_bib104","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10456-025-09975-7","article-title":"ApoM-bound S1P acts via endothelial S1PR1 to suppress choroidal neovascularization and vascular leakage","volume":"28","author":"Jung","year":"2025","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jbc.2026.111335_bib105","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1038\/s41467-025-60830-1","article-title":"Apolipoprotein M attenuates age-related macular degeneration phenotypes via sphingosine-1-phosphate signaling and lysosomal lipid catabolism","volume":"16","author":"Lee","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111335_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.838223","article-title":"Association between Plasma Apolipoprotein M with Alzheimer's Disease: a cross-sectional pilot study from China","volume":"14","author":"Xin","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jbc.2026.111335_bib107","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tcm.2019.11.001","article-title":"Chronic inflammation, cardiometabolic diseases and effects of treatment: psoriasis as a human model","volume":"30","author":"Aksentijevich","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib108","first-page":"367","article-title":"[Association of serum level of apolipoprotein M with disease activity in systemic lupus erythematosus]","volume":"40","author":"Du","year":"2015","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jbc.2026.111335_bib109","first-page":"e93","article-title":"Measurement of apolipoprotein M in sepsis-related deaths Clin","volume":"53","author":"Palmiere","year":"2015","journal-title":"Chem. Lab Med."},{"key":"10.1016\/j.jbc.2026.111335_bib110","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1825849","article-title":"Apolipoprotein M serum levels correlate with IgA vasculitis and IgA vasculitis nephritis","volume":"2019","author":"Wu","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jbc.2026.111335_bib111","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut Microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib112","article-title":"Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19 EMBO","volume":"13","author":"Marfia","year":"2021","journal-title":"Mol. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2020.00018","article-title":"C-Reactive protein causes adult-onset obesity through chronic inflammatory mechanism","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jbc.2026.111335_bib114","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2026.111335_bib115","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.121.054516","article-title":"Social vulnerability and premature cardiovascular mortality among US counties, 2014 to 2018","volume":"144","author":"Khan","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2026.111335_bib116","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40263-015-0261-z","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis","volume":"29","author":"Subei","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jbc.2026.111335_bib117","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","article-title":"Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2026.111335_bib118","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib119","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/jnnp-2015-310597","article-title":"Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study","volume":"87","author":"Cohen","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jbc.2026.111335_bib120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1161\/CIRCULATIONAHA.113.002683","article-title":"Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease","volume":"128","author":"Kingwell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2026.111335_bib121","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacc.2008.12.008","article-title":"Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes","volume":"53","author":"Patel","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jbc.2026.111335_bib122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-020-00902-3","article-title":"High HDL-cholesterol paradox: SCARB1-LAG3-HDL axis","volume":"23","author":"Rodriguez","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.jbc.2026.111335_bib123","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib124","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","volume":"35","author":"Tardif","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jbc.2026.111335_bib125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1210\/me.2005-0209","article-title":"Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M","volume":"20","author":"Faber","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2026.111335_bib126","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adg9256","article-title":"Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation","volume":"17","author":"Lin","year":"2024","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2026.111335_bib127","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216645","article-title":"Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative retinal neovascularization","volume":"15","author":"Niaudet","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2000.tb05564.x","article-title":"Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism","volume":"924","author":"Poirier","year":"2000","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.jbc.2026.111335_bib129","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.devcel.2020.01.016","article-title":"Sphingosine 1-Phosphate receptor signaling establishes AP-1 gradients to allow for retinal endothelial cell specialization","volume":"52","author":"Yanagida","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2026.111335_bib130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.devcel.2020.05.024","article-title":"Aging suppresses Sphingosine-1-Phosphate chaperone ApoM in circulation resulting in maladaptive organ repair","volume":"53","author":"Ding","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2026.111335_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1352842","article-title":"Kinetic modeling of the plasma pharmacokinetic profiles of ADAMTS13 fragment and its Fc-fusion counterpart in mice","volume":"15","author":"Kwak","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111335_bib132","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1021\/jm000173z","article-title":"Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols","volume":"43","author":"Kiuchi","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jbc.2026.111335_bib133","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.intimp.2011.07.004","article-title":"The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice","volume":"11","author":"Tarrason","year":"2011","journal-title":"Int. Immunopharmacol"},{"key":"10.1016\/j.jbc.2026.111335_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108386","article-title":"Frontiers in diabetic retinal disease","volume":"37","author":"Torm","year":"2023","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.jbc.2026.111335_bib135","first-page":"334","article-title":"Sphingosine 1 phosphate receptor-1 (S1PR1) signaling protects cardiac function by inhibiting cardiomyocyte","volume":"15","author":"Chen","year":"2018","journal-title":"Autophagy J. Geriatr. Cardiol."},{"key":"10.1016\/j.jbc.2026.111335_bib136","first-page":"91","article-title":"Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during","volume":"40","author":"Epelman","year":"2014","journal-title":"Inflamm. Immun."},{"key":"10.1016\/j.jbc.2026.111335_bib137","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cvr\/cvp137","article-title":"Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion","volume":"83","author":"Hofmann","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib138","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/SHK.0000000000000908","article-title":"Sphingosine-1-Phosphate Receptor-1 agonist Sew2871 causes severe cardiac side effects and does not improve microvascular barrier breakdown in sepsis","volume":"49","author":"Flemming","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.jbc.2026.111335_bib139","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ni1269","article-title":"Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses","volume":"6","author":"Wei","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jbc.2026.111335_bib140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.RES.0000244088.33375.52","article-title":"Sphingosine-1 phosphate prevents monocyte\/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor","volume":"99","author":"Whetzel","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.jbc.2026.111335_bib141","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/FJC.0b013e318157a5fe","article-title":"S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias","volume":"50","author":"Tsukada","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111335_bib142","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-025-57124-x","article-title":"S1PR1-biased activation drives the resolution of endothelial dysfunction-associated inflammatory diseases by maintaining endothelial integrity","volume":"16","author":"Zheng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2026.111335_bib143","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax8050","article-title":"A G protein-biased S1P(1) agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers","volume":"13","author":"Poirier","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2026.111335_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257929","article-title":"A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome","volume":"17","author":"Evaristi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.111335_bib145","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/bcp.14632","article-title":"Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial","volume":"87","author":"Bergougnan","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111335_bib146","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of beta-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jbc.2026.111335_bib147","first-page":"7","article-title":"The use of biologics for targeting GPCRs in metastatic","volume":"14","author":"McBrien","year":"2025","journal-title":"Cancers Biotech. (Basel)"},{"key":"10.1016\/j.jbc.2026.111335_bib148","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G protein-coupled receptors: structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal. Transduct, Target. Ther."},{"key":"10.1016\/j.jbc.2026.111335_bib149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal. Transduct Target. Ther."},{"key":"10.1016\/j.jbc.2026.111335_bib150","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41587-019-0175-2","article-title":"Pre-market development times for biologic versus small-molecule drugs","volume":"37","author":"Beall","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2026.111335_bib151","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jb\/mvad037","article-title":"Apolipoprotein M supports S1P production and conservation and mediates prolonged Akt activation via S1PR1 and S1PR3","volume":"174","author":"Kiyozuka","year":"2023","journal-title":"J. Biochem."},{"key":"10.1016\/j.jbc.2026.111335_bib152","first-page":"1871","article-title":"Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice","volume":"119","author":"Camerer","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2026.111335_bib153","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.tips.2022.06.001","article-title":"Biologics and cardiac disease: challenges and opportunities","volume":"43","author":"Ciucci","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2026.111335_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-41199-1_1","article-title":"Therapeutic potential of small molecules and engineered proteins","volume":"219","author":"Gurevich","year":"2014","journal-title":"Handb Exp. Pharmacol."},{"key":"10.1016\/j.jbc.2026.111335_bib155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40259-015-0133-6","article-title":"Fusion proteins for half-life extension of biologics as a strategy to make biobetters","volume":"29","author":"Strohl","year":"2015","journal-title":"BioDrugs"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582600205X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582600205X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:52:10Z","timestamp":1777445530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582600205X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S002192582600205X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111335","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein M: Structural insights, functional roles, and therapeutic approaches in vascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.111335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"111335"}}